Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance of RapiGEN BIOCREDIT Malaria Ag RDTs for Detection of Plasmodium Infections in Patients With Symptoms Suggestive of Malaria

NCT05085301 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.

NCT NCT05085301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05085301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance of RapiGEN BIOCREDIT Malaria Ag RDTs for Detection of Plasmodium Infections in Patients With Symptoms Suggestive of Malaria
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
May 30, 2023
Enrollment
674 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diagnoses disease, malaria, rdt